The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 365-375

Springer Publishing Company

Access to resources Recommend Favorite

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 353-363

Springer Publishing Company

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

By Feikin D.R.   Elie C.M.   Goetz M.B.   Lennox J.L.   Carlone G.M.   Romero-Steiner S.   Holder P.F.   O'Brien W.A.   Whitney C.G.   Butler J.C.   Breiman R.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 545-553

Elsevier

Access to resources Recommend Favorite

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

By Honkanen P.O.   Keistinen T.   Miettinen L.   Herva E.   Sankilampi U.   Laara E.   Leinonen M.   Kivela S.-L.   Helena Makela P.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2493-2500

Elsevier

Access to resources Recommend Favorite